Sodium Sulfacetamide 10 % and Sulfur 2 % Cleanser

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Sodium Sulfacetamide 10 % and Sulfur 2 % Cleanser
Generic name: SODIUM SULFACETAMIDE AND SULFUR
Manufacturer: SOHM, Inc
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 480b4c92-45a1-4ac8-83ee-791abf1b8759
SPL ID: 67acba09-6267-4139-ad2b-e6b7849752a9
Version: 1
Effective date: 2023-05-03
Source export date: 2026-09-28
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:23:45

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Sodium Sulfacetamide 10 % and Sulfur 2 % Cleanser	openfda.brand_name
generic name		SODIUM SULFACETAMIDE AND SULFUR	openfda.generic_name
manufacturer name		SOHM, Inc	openfda.manufacturer_name
ndc	package	50405-851-01	openfda.package_ndc
ndc	product	50405-851	openfda.product_ndc
ndc11	package	50405085101	derived:openfda.package_ndc
rxcui		1000895	openfda.rxcui
spl id		67acba09-6267-4139-ad2b-e6b7849752a9	id
spl set id		480b4c92-45a1-4ac8-83ee-791abf1b8759	set_id
unii		4NRT660KJQ	openfda.unii
unii		70FD1KFU70	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: Although rare, sensitivity to Sulfacetaminde Sodium may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS: Although rare, Sulfacetamide Sodium may cause local irritation.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.